Making a case for the socioeconomic determinacy of survival in osteosarcoma

scientific article published on March 2013

Making a case for the socioeconomic determinacy of survival in osteosarcoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11999-012-2575-1
P932PMC publication ID3563779
P698PubMed publication ID22972655

P2093author name stringJohn H Healey
Saminathan S Nathan
P2860cites workComparative frequency of bone sarcomas among different racial groups.Q33271094
High dose ifosfamide in combination with high dose methotrexate, adriamycin and cisplatin in the neoadjuvant treatment of extremity osteosarcoma: preliminary results of an Italian Sarcoma Group/Scandinavian Sarcoma Group pilot studyQ33342456
Neoadjuvant chemotherapy for osteosarcoma of the extremity: long-term results of the Rizzoli's 4th protocol.Q34518343
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.Q34545093
Glucose-6-phosphate dehydrogenase deficiency in ChineseQ36530948
Osteogenic sarcoma under the age of twenty-one. A review of one hundred and forty-five operative casesQ40024188
Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacementQ40640520
Ethanol potentiates doxorubicin-induced inhibition of cell survival in cultured Chinese hamster ovary cellsQ41180872
Limb sparing versus amputation in osteosarcoma. Correlation between local control, surgical margins and tumor necrosis: Istituto Rizzoli experienceQ41977373
Human liver aldehyde dehydrogenase in Chinese and Asiatic Indians: Gene deletion and its possible implications in alcohol metabolismQ43617790
Limb-salvage treatment versus amputation for osteosarcoma of the distal end of the femurQ44305845
Osteogenic sarcoma in the American blackQ46507489
Potentiation of adriamycin toxicity by ethanol in perfused rat liver.Q50788991
Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experienceQ67530667
Recent advances in the chemotherapy of metastatic osteogenic sarcomaQ69102684
Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7)Q72023908
NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamideQ72547250
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectsocioeconomicsQ1643441
P304page(s)784-791
P577publication date2013-03-01
P1433published inClinical Orthopaedics and Related ResearchQ5133783
P1476titleMaking a case for the socioeconomic determinacy of survival in osteosarcoma
P478volume471